IP Library Assignment 054135/0165
Patent Assignment
Reel/Frame 054135/0165

Assignment of Assignor's Interest

Recorded: 2020-10-22 Pages: 7
Assignor
NOVARTIS AG
Executed: 2020-10-21
Assignee
NOVARTIS PHARMACEUTICALS CORPORATION
ONE HEALTH PLAZA, EAST HANOVER, NEW JERSEY, 07936
Covered Properties (20)
Compositions and Methods for Treatment of Eye Disorders
Application: 12/508,311 →
Publication: US 2010/0092541
Modulators of Cellular Adhesion
Application: 13/223,557 →
Publication: US 2012/0035154
Compositions and Methods for Treatment
Application: 13/962,369 →
Publication: US 2014/0073666
Compositions and Methods for Treatment
Application: 13/962,440 →
Publication: US 2014/0099387
Compositions and Methods for Treatment
Application: 14/609,743 →
Publication: US 2015/0140075
Compositions and Methods for Treatment
Application: 14/609,770 →
Publication: US 2015/0140076
Compositions and Methods for Treatment
Application: 14/609,795 →
Publication: US 2015/0216857
Compositions and Methods for Treatment
Application: 14/609,967 →
Publication: US 2015/0182520
Compositions and Methods for Treatment
Application: 14/610,346 →
Publication: US 2015/0175578
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Application: 15/235,572 →
Publication: US 2016/0368902
Compositions and Methods for Treatment
Application: 15/357,237 →
Publication: US 2017/0143690
Compositions and Methods for Treatment
Application: 15/364,935 →
Publication: US 2017/0143691
Compositions and Methods for Treatment
Application: 15/372,863 →
Publication: US 2017/0143692
Compositions and Methods for Treatment
Application: 15/373,604 →
Publication: US 2017/0143693
Modulators of Cellular Adhesion
Application: 16/172,197 →
Publication: US 2019/0134022
Lfa-1 Inhibitor and Methods of Preparation and Polymorph Thereof
Application: 16/247,843 →
Publication: US 2019/0382389
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Application: 61/045,142 →
LFA-1 Inhibitor and Methods of Preparation
Application: 61/675,663 →
LFA-1 Inhibitor and Methods of Preparation
Application: 61/680,099 →
LFA-1 Inhibitor and Methods of Preparation and Polymorph Thereof
Application: 61/729,294 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 13, 2010
From: ZHONG, MIN
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 025134/0219 →
Assignment of Assignor's Interest Oct 13, 2010
From: GADEK, THOMAS; BURNIER, JOHN
To: SARCODE CORPORATION
Reel/Frame 025134/0277 →
Assignment of Assignor's Interest Oct 22, 2010
From: SUNESIS PHARMACEUTICALS, INC.
To: SARCODE CORPORATION
Reel/Frame 025184/0125 →
Change of Name Sep 8, 2011
From: SARCODE CORPORATION
To: SARCODE BIOSCIENCE INC.
Reel/Frame 026876/0312 →
Security Agreement Feb 8, 2013
From: SARCODE BIOSCIENCE INC.
To: SILICON VALLEY BANK
Reel/Frame 029778/0888 →
Merger Feb 13, 2013
From: SARCODE, A CALIFORNIA CORPORATION
To: SARCODE CORPORATION, A CORPORATION OF STATE OF DELAWARE
Reel/Frame 029804/0051 →
Release of Security Interest Apr 25, 2013
From: SILICON VALLEY BANK
To: SARCODE BIOSCIENCE INC.
Reel/Frame 030295/0028 →
Assignment of Assignor's Interest Feb 10, 2017
From: SUNESIS PHARMACEUTICALS, INC.
To: SARCODE CORPORATION
Reel/Frame 041222/0713 →
Assignment of Assignor's Interest Feb 10, 2017
From: GADEK, THOMAS; BURNIER, JOHN
To: SARCODE CORPORATION
Reel/Frame 041222/0615 →
Change of Name Feb 10, 2017
From: SARCODE CORPORATION
To: SARCODE BIOSCIENCE INC.
Reel/Frame 041679/0972 →
Assignment of Assignor's Interest Feb 10, 2017
From: SHEN, WANG; OSLOB, JOHAN D.; BARR, KENNETH; ZHONG, MIN
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 041222/0673 →
Assignment of Assignor's Interest Apr 15, 2019
From: SHEN, WANG; BARR, KENNETH; OSLOB, JOHAN D.; ZHONG, MIN
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 048880/0447 →
Change of Name Apr 15, 2019
From: SARCODE CORPORATION
To: SARCODE BIOSCIENCE INC.
Reel/Frame 050261/0110 →
Assignment of Assignor's Interest Apr 15, 2019
From: SUNESIS PHARMACEUTICALS, INC.
To: SARCODE CORPORATION
Reel/Frame 048880/0466 →
Security Agreement May 29, 2019
From: SARCODE BIOSCIENCE INC.
To: SILICON VALLEY BANK
Reel/Frame 049314/0095 →
Change of Name May 29, 2019
From: SARCODE CORPORATION
To: SARCODE BIOSCIENCE INC.
Reel/Frame 050445/0953 →
Release of Security Interest May 30, 2019
From: SILICON VALLEY BANK
To: SARCODE BIOSCIENCE INC.
Reel/Frame 049314/0700 →
Assignment of Assignor's Interest Jun 4, 2019
From: ALBANY MOLECULAR RESEARCH, INC.
To: SARCODE BIOSCIENCE INC.
Reel/Frame 049360/0783 →
Assignment of Assignor's Interest Jun 4, 2019
From: ALBANY MOLECULAR RESEARCH, INC.
To: SARCODE BIOSCIENCE INC.
Reel/Frame 049362/0311 →
Assignment of Assignor's Interest Jun 4, 2019
From: VENKATRAMAN, SRIPATHY; BROT, ELISABETH C.A.; IYER, SUBASHREE; HALL, MICHAEL
To: ALBANY MOLECULAR RESEARCH INC.
Reel/Frame 049362/0037 →
Assignment of Assignor's Interest Jun 4, 2019
From: ZELLER, JAMES ROBERT
To: SARCODE BIOSCIENCE INC.
Reel/Frame 049360/0957 →
Assignment of Assignor's Interest Jun 4, 2019
From: ZELLER, JAMES ROBERT
To: SARCODE BIOSCIENCE INC.
Reel/Frame 049360/0578 →
Assignment of Assignor's Interest Jun 4, 2019
From: VENKATRAMAN, SRIPATHY; BROT, ELISABETH C.A.
To: ALBANY MOLECULAR RESEARCH INC.
Reel/Frame 049360/0354 →
Assignment of Assignor's Interest Oct 31, 2019
From: SARCODE BIOSCIENCE INC.
To: NOVARTIS AG
Reel/Frame 050900/0268 →
Assignment of Assignor's Interest Apr 21, 2020
From: SARCODE BIOSCIENCE INC.
To: NOVARTIS AG
Reel/Frame 052459/0278 →